The main objective is to determine the clinical utility of non-invasive methods for measuring fibrosis in the initial assessment and follow-up of chronic hepatitis B in untreated adults.
In the absence of sufficient demonstration of this clinical utility, the diagnostic performances of these non-invasive methods will be defined, in comparison with liver biopsy
See also
HAS opinions and decisions
19/06/2014
Practice guidelines
07/05/2009
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
rFjzpDv725GHMnw2